These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37187260)

  • 21. Approaches to measure protein binding of enzymatically unstable compounds in plasma.
    Ye Z; Gao H
    Bioanalysis; 2018 Apr; 10(7):451-459. PubMed ID: 29633861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the importance of plasma protein binding in drug discovery and development.
    Di L
    Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of unbound fraction of dorzagliatin in human plasma by equilibrium dialysis and LC-MS/MS and its application to a clinical pharmacokinetic study.
    Yang R; Ren S; Jin X; Sun Y; Dong Y; Zhang J; Liang W; Chen L
    J Pharm Biomed Anal; 2021 Feb; 195():113854. PubMed ID: 33388639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Commonly Used and New Methods to Determine Small Molecule Non-Specific Binding to Human Liver Microsomes.
    Wang T; Whitcher-Johnstone A; Scaringella YS; Keith-Luzzi M; Shao J; Taub ME; Chan TS
    J Pharm Sci; 2024 Jul; 113(7):1987-1995. PubMed ID: 38615815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of recovery on fraction unbound using equilibrium dialysis.
    Di L; Umland JP; Trapa PE; Maurer TS
    J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.
    Waters NJ; Jones R; Williams G; Sohal B
    J Pharm Sci; 2008 Oct; 97(10):4586-95. PubMed ID: 18300299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
    Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
    J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients.
    Li J; Brahmer J; Messersmith W; Hidalgo M; Baker SD
    Invest New Drugs; 2006 Jul; 24(4):291-7. PubMed ID: 16502356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semi-automated protein binding methodology using equilibrium dialysis and a novel mixed-matrix cassette approach.
    Plise EG; Tran D; Salphati L
    J Pharm Sci; 2010 Dec; 99(12):5070-8. PubMed ID: 20821380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum.
    Jung D; Mayersohn M; Perrier D
    Clin Chem; 1981 Jan; 27(1):166-8. PubMed ID: 7449102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.
    Wang C; Williams NS
    J Pharm Biomed Anal; 2013 Mar; 75():112-7. PubMed ID: 23312388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of equilibrium dialysis methods employing biological and artificial membranes for the determination of protein binding of drugs.
    Hinderling PH
    Ther Drug Monit; 1987 Sep; 9(3):331-6. PubMed ID: 3672577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.
    Isbell J; Yuan D; Torrao L; Gatlik E; Hoffmann L; Wipfli P
    J Pharm Sci; 2019 Feb; 108(2):1053-1060. PubMed ID: 30336155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Pharmacol Methods; 1982 Jan; 7(1):7-14. PubMed ID: 7070107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry.
    Lin ZJ; Musiano D; Abbot A; Shum L
    J Pharm Biomed Anal; 2005 Apr; 37(4):757-62. PubMed ID: 15797798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.